关于
  • English
  • About
    • Management
    • Board of Directors
    • Strategic Advisory Board
    • Our Partners
    • Proprietary Platform Technology
    • About TFChem
  • Programs
    • Pipeline
      • Antiviral
    • Skincare – Dark Spot Correction
    • Skincare – GlycoProteMim™
  • News
    • Sirona News
    • Events
  • Investors
    • Financial Information
    • Financial Reports
    • Investor & Media Kit
    • Newsletter
    • AGM
  • Contact
  • Careers

April 22nd, 2025

Sirona Biochem Announces Debenture Financing

April 22nd, 2025

Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH

January 15th, 2025

Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare’s Landmark Report

November 20th, 2024

Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology

October 22nd, 2024

Stonegate Initiates Coverage on Sirona Biochem Corp.

  • 1
  • 2
  • 3
  • …
  • 30
  • Next Page »

Archives

  • About
  • TFChem
  • Programs
  • News
  • Investors
  • Contact

© 2025 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
555 Burrard St.
Vancouver, B.C., Canada,V7X1M8

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

© 2025 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
595 Burrard St.
Vancouver, B.C., Canada,V7X 1L4

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

Enter your info below to subscribe to our newsletter:
Loading